aluates Reports

$ 0.0

Automative

Global Lipid Nanoparticle (LNP) CDMO Service Market Research Report 2026

Published Date: 2026-01-08

Report Code: QYRE-Auto-16H20264

BUY CHAPTERS

Global Lipid Nanoparticle (LNP) CDMO Service Market Research Report 2026

Code: QYRE-Auto-16H20264

Report

2026-01-08

Pages:144

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Lipid Nanoparticle (LNP) CDMO Service Market Size

The global Lipid Nanoparticle (LNP) CDMO Service market was valued at US$ 742 million in 2025 and is anticipated to reach US$ 1140 million by 2032, at a CAGR of 6.3% from 2026 to 2032.

Lipid Nanoparticle (LNP) CDMO Service Market

Lipid Nanoparticle (LNP) CDMO Service refers to a specialized contract research and manufacturing service dedicated to supporting biopharmaceutical companies, biotech startups, and research institutions in the full lifecycle development and production of lipid nanoparticles— the gold-standard delivery vehicles for nucleic acid therapeutics including mRNA vaccines, siRNA gene silencing therapies, and CRISPR-based gene editing platforms.

The North American market for Lipid Nanoparticle (LNP) CDMO Service is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Lipid Nanoparticle (LNP) CDMO Service is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Lipid Nanoparticle (LNP) CDMO Service in Vaccine Development is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Lipid Nanoparticle (LNP) CDMO Service include Evonik, Helix Biotech, FUJIFILM Holdings, Merck, Ascendia Pharmaceuticals, Catalent, Polymun Scientific, Genevant Sciences, Cytiva, Croda International, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Lipid Nanoparticle (LNP) CDMO Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lipid Nanoparticle (LNP) CDMO Service. The Lipid Nanoparticle (LNP) CDMO Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Lipid Nanoparticle (LNP) CDMO Service market comprehensively. Regional market sizes by Type, by Application, by Nucleic Acid Type, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Lipid Nanoparticle (LNP) CDMO Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Lipid Nanoparticle (LNP) CDMO Service Market Report

Report Metric	Details
Report Name	Lipid Nanoparticle (LNP) CDMO Service Market
Accounted market size in 2025	US$ 742 million
Forecasted market size in 2032	US$ 1140 million
CAGR	6.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Formulation Development cGMP Manufacturing Others
Segment by Nucleic Acid Type	mRNA-LNP CDMO Service siRNA-LNP CDMO Service Others
Segment by Application	Vaccine Development Gene Therapy Drug Delivery Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Evonik, Helix Biotech, FUJIFILM Holdings, Merck, Ascendia Pharmaceuticals, Catalent, Polymun Scientific, Genevant Sciences, Cytiva, Croda International, Nippon Fine Chemical, Patheon, Biomay, Pace Analytical, CordenPharma, Vernal Biosciences, Lonza, Acuitas Therapeutics, Creative Biolabs, WuXi STA, GenScript, MicroNano Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Nucleic Acid Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Lipid Nanoparticle (LNP) CDMO Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Lipid Nanoparticle (LNP) CDMO Service Market growing?

Ans: The Lipid Nanoparticle (LNP) CDMO Service Market witnessing a CAGR of 6.3% during the forecast period 2026-2032.

What is the Lipid Nanoparticle (LNP) CDMO Service Market size in 2032?

Ans: The Lipid Nanoparticle (LNP) CDMO Service Market size in 2032 will be US$ 1140 million.

Who are the main players in the Lipid Nanoparticle (LNP) CDMO Service Market report?

Ans: The main players in the Lipid Nanoparticle (LNP) CDMO Service Market are Evonik, Helix Biotech, FUJIFILM Holdings, Merck, Ascendia Pharmaceuticals, Catalent, Polymun Scientific, Genevant Sciences, Cytiva, Croda International, Nippon Fine Chemical, Patheon, Biomay, Pace Analytical, CordenPharma, Vernal Biosciences, Lonza, Acuitas Therapeutics, Creative Biolabs, WuXi STA, GenScript, MicroNano Biologics

What are the Application segmentation covered in the Lipid Nanoparticle (LNP) CDMO Service Market report?

Ans: The Applications covered in the Lipid Nanoparticle (LNP) CDMO Service Market report are Vaccine Development, Gene Therapy, Drug Delivery, Others

What are the Type segmentation covered in the Lipid Nanoparticle (LNP) CDMO Service Market report?

Ans: The Types covered in the Lipid Nanoparticle (LNP) CDMO Service Market report are mRNA-LNP CDMO Service, siRNA-LNP CDMO Service, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lipid Nanoparticle (LNP) CDMO Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Formulation Development

1.2.3 cGMP Manufacturing

1.2.4 Others

1.3 Market by Nucleic Acid Type

1.3.1 Global Lipid Nanoparticle (LNP) CDMO Service Market Size Growth Rate by Nucleic Acid Type: 2021 vs 2025 vs 2032

1.3.2 mRNA-LNP CDMO Service

1.3.3 siRNA-LNP CDMO Service

1.3.4 Others

1.4 Market by Application

1.4.1 Global Lipid Nanoparticle (LNP) CDMO Service Market Growth by Application: 2021 vs 2025 vs 2032

1.4.2 Vaccine Development

1.4.3 Gene Therapy

1.4.4 Drug Delivery

1.4.5 Others

1.5 Assumptions and Limitations

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Global Lipid Nanoparticle (LNP) CDMO Service Market Perspective (2021–2032)

2.2 Global Lipid Nanoparticle (LNP) CDMO Service Growth Trends by Region

2.2.1 Global Lipid Nanoparticle (LNP) CDMO Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Lipid Nanoparticle (LNP) CDMO Service Historic Market Size by Region (2021–2026)

2.2.3 Lipid Nanoparticle (LNP) CDMO Service Forecasted Market Size by Region (2027–2032)

2.3 Lipid Nanoparticle (LNP) CDMO Service Market Dynamics

2.3.1 Lipid Nanoparticle (LNP) CDMO Service Industry Trends

2.3.2 Lipid Nanoparticle (LNP) CDMO Service Market Drivers

2.3.3 Lipid Nanoparticle (LNP) CDMO Service Market Challenges

2.3.4 Lipid Nanoparticle (LNP) CDMO Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lipid Nanoparticle (LNP) CDMO Service Players by Revenue

3.1.1 Global Top Lipid Nanoparticle (LNP) CDMO Service Players by Revenue (2021–2026)

3.1.2 Global Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Players (2021–2026)

3.2 Global Top Lipid Nanoparticle (LNP) CDMO Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Lipid Nanoparticle (LNP) CDMO Service Revenue

3.4 Global Lipid Nanoparticle (LNP) CDMO Service Market Concentration Ratio

3.4.1 Global Lipid Nanoparticle (LNP) CDMO Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lipid Nanoparticle (LNP) CDMO Service Revenue in 2025

3.5 Global Key Players of Lipid Nanoparticle (LNP) CDMO Service Head Offices and Areas Served

3.6 Global Key Players of Lipid Nanoparticle (LNP) CDMO Service, Products and Applications

3.7 Global Key Players of Lipid Nanoparticle (LNP) CDMO Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Lipid Nanoparticle (LNP) CDMO Service Breakdown Data by Type

4.1 Global Lipid Nanoparticle (LNP) CDMO Service Historic Market Size by Type (2021–2026)

4.2 Global Lipid Nanoparticle (LNP) CDMO Service Forecasted Market Size by Type (2027–2032)

5 Lipid Nanoparticle (LNP) CDMO Service Breakdown Data by Application

5.1 Global Lipid Nanoparticle (LNP) CDMO Service Historic Market Size by Application (2021–2026)

5.2 Global Lipid Nanoparticle (LNP) CDMO Service Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Lipid Nanoparticle (LNP) CDMO Service Market Size (2021–2032)

6.2 North America Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2021–2026)

6.4 North America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lipid Nanoparticle (LNP) CDMO Service Market Size (2021–2032)

7.2 Europe Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2021–2026)

7.4 Europe Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Size (2021–2032)

8.2 Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Size by Region (2021–2026)

8.4 Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Lipid Nanoparticle (LNP) CDMO Service Market Size (2021–2032)

9.2 Latin America Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2021–2026)

9.4 Latin America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Size (2021–2032)

10.2 Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2021–2026)

10.4 Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Evonik

11.1.1 Evonik Company Details

11.1.2 Evonik Business Overview

11.1.3 Evonik Lipid Nanoparticle (LNP) CDMO Service Introduction

11.1.4 Evonik Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.1.5 Evonik Recent Development

11.2 Helix Biotech

11.2.1 Helix Biotech Company Details

11.2.2 Helix Biotech Business Overview

11.2.3 Helix Biotech Lipid Nanoparticle (LNP) CDMO Service Introduction

11.2.4 Helix Biotech Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.2.5 Helix Biotech Recent Development

11.3 FUJIFILM Holdings

11.3.1 FUJIFILM Holdings Company Details

11.3.2 FUJIFILM Holdings Business Overview

11.3.3 FUJIFILM Holdings Lipid Nanoparticle (LNP) CDMO Service Introduction

11.3.4 FUJIFILM Holdings Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.3.5 FUJIFILM Holdings Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Lipid Nanoparticle (LNP) CDMO Service Introduction

11.4.4 Merck Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.4.5 Merck Recent Development

11.5 Ascendia Pharmaceuticals

11.5.1 Ascendia Pharmaceuticals Company Details

11.5.2 Ascendia Pharmaceuticals Business Overview

11.5.3 Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) CDMO Service Introduction

11.5.4 Ascendia Pharmaceuticals Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.5.5 Ascendia Pharmaceuticals Recent Development

11.6 Catalent

11.6.1 Catalent Company Details

11.6.2 Catalent Business Overview

11.6.3 Catalent Lipid Nanoparticle (LNP) CDMO Service Introduction

11.6.4 Catalent Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.6.5 Catalent Recent Development

11.7 Polymun Scientific

11.7.1 Polymun Scientific Company Details

11.7.2 Polymun Scientific Business Overview

11.7.3 Polymun Scientific Lipid Nanoparticle (LNP) CDMO Service Introduction

11.7.4 Polymun Scientific Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.7.5 Polymun Scientific Recent Development

11.8 Genevant Sciences

11.8.1 Genevant Sciences Company Details

11.8.2 Genevant Sciences Business Overview

11.8.3 Genevant Sciences Lipid Nanoparticle (LNP) CDMO Service Introduction

11.8.4 Genevant Sciences Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.8.5 Genevant Sciences Recent Development

11.9 Cytiva

11.9.1 Cytiva Company Details

11.9.2 Cytiva Business Overview

11.9.3 Cytiva Lipid Nanoparticle (LNP) CDMO Service Introduction

11.9.4 Cytiva Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.9.5 Cytiva Recent Development

11.10 Croda International

11.10.1 Croda International Company Details

11.10.2 Croda International Business Overview

11.10.3 Croda International Lipid Nanoparticle (LNP) CDMO Service Introduction

11.10.4 Croda International Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.10.5 Croda International Recent Development

11.11 Nippon Fine Chemical

11.11.1 Nippon Fine Chemical Company Details

11.11.2 Nippon Fine Chemical Business Overview

11.11.3 Nippon Fine Chemical Lipid Nanoparticle (LNP) CDMO Service Introduction

11.11.4 Nippon Fine Chemical Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.11.5 Nippon Fine Chemical Recent Development

11.12 Patheon

11.12.1 Patheon Company Details

11.12.2 Patheon Business Overview

11.12.3 Patheon Lipid Nanoparticle (LNP) CDMO Service Introduction

11.12.4 Patheon Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.12.5 Patheon Recent Development

11.13 Biomay

11.13.1 Biomay Company Details

11.13.2 Biomay Business Overview

11.13.3 Biomay Lipid Nanoparticle (LNP) CDMO Service Introduction

11.13.4 Biomay Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.13.5 Biomay Recent Development

11.14 Pace Analytical

11.14.1 Pace Analytical Company Details

11.14.2 Pace Analytical Business Overview

11.14.3 Pace Analytical Lipid Nanoparticle (LNP) CDMO Service Introduction

11.14.4 Pace Analytical Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.14.5 Pace Analytical Recent Development

11.15 CordenPharma

11.15.1 CordenPharma Company Details

11.15.2 CordenPharma Business Overview

11.15.3 CordenPharma Lipid Nanoparticle (LNP) CDMO Service Introduction

11.15.4 CordenPharma Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.15.5 CordenPharma Recent Development

11.16 Vernal Biosciences

11.16.1 Vernal Biosciences Company Details

11.16.2 Vernal Biosciences Business Overview

11.16.3 Vernal Biosciences Lipid Nanoparticle (LNP) CDMO Service Introduction

11.16.4 Vernal Biosciences Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.16.5 Vernal Biosciences Recent Development

11.17 Lonza

11.17.1 Lonza Company Details

11.17.2 Lonza Business Overview

11.17.3 Lonza Lipid Nanoparticle (LNP) CDMO Service Introduction

11.17.4 Lonza Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.17.5 Lonza Recent Development

11.18 Acuitas Therapeutics

11.18.1 Acuitas Therapeutics Company Details

11.18.2 Acuitas Therapeutics Business Overview

11.18.3 Acuitas Therapeutics Lipid Nanoparticle (LNP) CDMO Service Introduction

11.18.4 Acuitas Therapeutics Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.18.5 Acuitas Therapeutics Recent Development

11.19 Creative Biolabs

11.19.1 Creative Biolabs Company Details

11.19.2 Creative Biolabs Business Overview

11.19.3 Creative Biolabs Lipid Nanoparticle (LNP) CDMO Service Introduction

11.19.4 Creative Biolabs Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.19.5 Creative Biolabs Recent Development

11.20 WuXi STA

11.20.1 WuXi STA Company Details

11.20.2 WuXi STA Business Overview

11.20.3 WuXi STA Lipid Nanoparticle (LNP) CDMO Service Introduction

11.20.4 WuXi STA Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.20.5 WuXi STA Recent Development

11.21 GenScript

11.21.1 GenScript Company Details

11.21.2 GenScript Business Overview

11.21.3 GenScript Lipid Nanoparticle (LNP) CDMO Service Introduction

11.21.4 GenScript Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.21.5 GenScript Recent Development

11.22 MicroNano Biologics

11.22.1 MicroNano Biologics Company Details

11.22.2 MicroNano Biologics Business Overview

11.22.3 MicroNano Biologics Lipid Nanoparticle (LNP) CDMO Service Introduction

11.22.4 MicroNano Biologics Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

11.22.5 MicroNano Biologics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Lipid Nanoparticle (LNP) CDMO Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Formulation Development

Table 3. Key Players of cGMP Manufacturing

Table 4. Key Players of Others

Table 5. Global Lipid Nanoparticle (LNP) CDMO Service Market Size Growth Rate by Nucleic Acid Type (US$ Million): 2021 vs 2025 vs 2032

Table 6. Key Players of mRNA-LNP CDMO Service

Table 7. Key Players of siRNA-LNP CDMO Service

Table 8. Key Players of Others

Table 9. Global Lipid Nanoparticle (LNP) CDMO Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global Lipid Nanoparticle (LNP) CDMO Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 11. Global Lipid Nanoparticle (LNP) CDMO Service Market Size by Region (US$ Million), 2021–2026

Table 12. Global Lipid Nanoparticle (LNP) CDMO Service Market Share by Region (2021–2026)

Table 13. Global Lipid Nanoparticle (LNP) CDMO Service Forecasted Market Size by Region (US$ Million), 2027–2032

Table 14. Global Lipid Nanoparticle (LNP) CDMO Service Market Share by Region (2027–2032)

Table 15. Lipid Nanoparticle (LNP) CDMO Service Market Trends

Table 16. Lipid Nanoparticle (LNP) CDMO Service Market Drivers

Table 17. Lipid Nanoparticle (LNP) CDMO Service Market Challenges

Table 18. Lipid Nanoparticle (LNP) CDMO Service Market Restraints

Table 19. Global Lipid Nanoparticle (LNP) CDMO Service Revenue by Players (US$ Million), 2021–2026

Table 20. Global Lipid Nanoparticle (LNP) CDMO Service Market Share by Players (2021–2026)

Table 21. Global Top Lipid Nanoparticle (LNP) CDMO Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Lipid Nanoparticle (LNP) CDMO Service Revenue, 2025

Table 22. Ranking of Global Top Lipid Nanoparticle (LNP) CDMO Service Companies by Revenue (US$ Million) in 2025

Table 23. Global 5 Largest Players Market Share by Lipid Nanoparticle (LNP) CDMO Service Revenue (CR5 and HHI), 2021–2026

Table 24. Global Key Players of Lipid Nanoparticle (LNP) CDMO Service, Headquarters and Area Served

Table 25. Global Key Players of Lipid Nanoparticle (LNP) CDMO Service, Products and Applications

Table 26. Global Key Players of Lipid Nanoparticle (LNP) CDMO Service, Date of General Availability (GA)

Table 27. Mergers and Acquisitions, Expansion Plans

Table 28. Global Lipid Nanoparticle (LNP) CDMO Service Market Size by Type (US$ Million), 2021–2026

Table 29. Global Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Type (2021–2026)

Table 30. Global Lipid Nanoparticle (LNP) CDMO Service Forecasted Market Size by Type (US$ Million), 2027–2032

Table 31. Global Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Type (2027–2032)

Table 32. Global Lipid Nanoparticle (LNP) CDMO Service Market Size by Application (US$ Million), 2021–2026

Table 33. Global Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Application (2021–2026)

Table 34. Global Lipid Nanoparticle (LNP) CDMO Service Forecasted Market Size by Application (US$ Million), 2027–2032

Table 35. Global Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Application (2027–2032)

Table 36. North America Lipid Nanoparticle (LNP) CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. North America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 38. North America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 39. Europe Lipid Nanoparticle (LNP) CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. Europe Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 41. Europe Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 42. Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 43. Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Size by Region (US$ Million), 2021–2026

Table 44. Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Size by Region (US$ Million), 2027–2032

Table 45. Latin America Lipid Nanoparticle (LNP) CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Latin America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 47. Latin America Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 48. Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 50. Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 51. Evonik Company Details

Table 52. Evonik Business Overview

Table 53. Evonik Lipid Nanoparticle (LNP) CDMO Service Product

Table 54. Evonik Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 55. Evonik Recent Development

Table 56. Helix Biotech Company Details

Table 57. Helix Biotech Business Overview

Table 58. Helix Biotech Lipid Nanoparticle (LNP) CDMO Service Product

Table 59. Helix Biotech Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 60. Helix Biotech Recent Development

Table 61. FUJIFILM Holdings Company Details

Table 62. FUJIFILM Holdings Business Overview

Table 63. FUJIFILM Holdings Lipid Nanoparticle (LNP) CDMO Service Product

Table 64. FUJIFILM Holdings Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 65. FUJIFILM Holdings Recent Development

Table 66. Merck Company Details

Table 67. Merck Business Overview

Table 68. Merck Lipid Nanoparticle (LNP) CDMO Service Product

Table 69. Merck Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 70. Merck Recent Development

Table 71. Ascendia Pharmaceuticals Company Details

Table 72. Ascendia Pharmaceuticals Business Overview

Table 73. Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) CDMO Service Product

Table 74. Ascendia Pharmaceuticals Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 75. Ascendia Pharmaceuticals Recent Development

Table 76. Catalent Company Details

Table 77. Catalent Business Overview

Table 78. Catalent Lipid Nanoparticle (LNP) CDMO Service Product

Table 79. Catalent Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 80. Catalent Recent Development

Table 81. Polymun Scientific Company Details

Table 82. Polymun Scientific Business Overview

Table 83. Polymun Scientific Lipid Nanoparticle (LNP) CDMO Service Product

Table 84. Polymun Scientific Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 85. Polymun Scientific Recent Development

Table 86. Genevant Sciences Company Details

Table 87. Genevant Sciences Business Overview

Table 88. Genevant Sciences Lipid Nanoparticle (LNP) CDMO Service Product

Table 89. Genevant Sciences Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 90. Genevant Sciences Recent Development

Table 91. Cytiva Company Details

Table 92. Cytiva Business Overview

Table 93. Cytiva Lipid Nanoparticle (LNP) CDMO Service Product

Table 94. Cytiva Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 95. Cytiva Recent Development

Table 96. Croda International Company Details

Table 97. Croda International Business Overview

Table 98. Croda International Lipid Nanoparticle (LNP) CDMO Service Product

Table 99. Croda International Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 100. Croda International Recent Development

Table 101. Nippon Fine Chemical Company Details

Table 102. Nippon Fine Chemical Business Overview

Table 103. Nippon Fine Chemical Lipid Nanoparticle (LNP) CDMO Service Product

Table 104. Nippon Fine Chemical Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 105. Nippon Fine Chemical Recent Development

Table 106. Patheon Company Details

Table 107. Patheon Business Overview

Table 108. Patheon Lipid Nanoparticle (LNP) CDMO Service Product

Table 109. Patheon Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 110. Patheon Recent Development

Table 111. Biomay Company Details

Table 112. Biomay Business Overview

Table 113. Biomay Lipid Nanoparticle (LNP) CDMO Service Product

Table 114. Biomay Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 115. Biomay Recent Development

Table 116. Pace Analytical Company Details

Table 117. Pace Analytical Business Overview

Table 118. Pace Analytical Lipid Nanoparticle (LNP) CDMO Service Product

Table 119. Pace Analytical Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 120. Pace Analytical Recent Development

Table 121. CordenPharma Company Details

Table 122. CordenPharma Business Overview

Table 123. CordenPharma Lipid Nanoparticle (LNP) CDMO Service Product

Table 124. CordenPharma Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 125. CordenPharma Recent Development

Table 126. Vernal Biosciences Company Details

Table 127. Vernal Biosciences Business Overview

Table 128. Vernal Biosciences Lipid Nanoparticle (LNP) CDMO Service Product

Table 129. Vernal Biosciences Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 130. Vernal Biosciences Recent Development

Table 131. Lonza Company Details

Table 132. Lonza Business Overview

Table 133. Lonza Lipid Nanoparticle (LNP) CDMO Service Product

Table 134. Lonza Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 135. Lonza Recent Development

Table 136. Acuitas Therapeutics Company Details

Table 137. Acuitas Therapeutics Business Overview

Table 138. Acuitas Therapeutics Lipid Nanoparticle (LNP) CDMO Service Product

Table 139. Acuitas Therapeutics Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 140. Acuitas Therapeutics Recent Development

Table 141. Creative Biolabs Company Details

Table 142. Creative Biolabs Business Overview

Table 143. Creative Biolabs Lipid Nanoparticle (LNP) CDMO Service Product

Table 144. Creative Biolabs Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 145. Creative Biolabs Recent Development

Table 146. WuXi STA Company Details

Table 147. WuXi STA Business Overview

Table 148. WuXi STA Lipid Nanoparticle (LNP) CDMO Service Product

Table 149. WuXi STA Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 150. WuXi STA Recent Development

Table 151. GenScript Company Details

Table 152. GenScript Business Overview

Table 153. GenScript Lipid Nanoparticle (LNP) CDMO Service Product

Table 154. GenScript Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 155. GenScript Recent Development

Table 156. MicroNano Biologics Company Details

Table 157. MicroNano Biologics Business Overview

Table 158. MicroNano Biologics Lipid Nanoparticle (LNP) CDMO Service Product

Table 159. MicroNano Biologics Revenue in Lipid Nanoparticle (LNP) CDMO Service Business (US$ Million), 2021–2026

Table 160. MicroNano Biologics Recent Development

Table 161. Research Programs/Design for This Report

Table 162. Key Data Information from Secondary Sources

Table 163. Key Data Information from Primary Sources

Table 164. Authors List of This Report

List of Figures

Figure 1. Lipid Nanoparticle (LNP) CDMO Service Picture

Figure 2. Global Lipid Nanoparticle (LNP) CDMO Service Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Lipid Nanoparticle (LNP) CDMO Service Market Share by Type: 2025 vs 2032

Figure 4. Formulation Development Features

Figure 5. cGMP Manufacturing Features

Figure 6. Others Features

Figure 7. Global Lipid Nanoparticle (LNP) CDMO Service Market Size Comparison by Nucleic Acid Type (US$ Million), 2021–2032

Figure 8. mRNA-LNP CDMO Service Features

Figure 9. siRNA-LNP CDMO Service Features

Figure 10. Others Features

Figure 11. Global Lipid Nanoparticle (LNP) CDMO Service Market Size by Application (US$ Million), 2021–2032

Figure 12. Global Lipid Nanoparticle (LNP) CDMO Service Market Share by Application: 2025 vs 2032

Figure 13. Vaccine Development Case Studies

Figure 14. Gene Therapy Case Studies

Figure 15. Drug Delivery Case Studies

Figure 16. Others Case Studies

Figure 17. Lipid Nanoparticle (LNP) CDMO Service Report Years Considered

Figure 18. Global Lipid Nanoparticle (LNP) CDMO Service Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 19. Global Lipid Nanoparticle (LNP) CDMO Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 20. Global Lipid Nanoparticle (LNP) CDMO Service Market Share by Region: 2025 vs 2032

Figure 21. Global Lipid Nanoparticle (LNP) CDMO Service Market Share by Players in 2025

Figure 22. Global Lipid Nanoparticle (LNP) CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 23. The Top 10 and 5 Players Market Share by Lipid Nanoparticle (LNP) CDMO Service Revenue in 2025

Figure 24. North America Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. North America Lipid Nanoparticle (LNP) CDMO Service Market Share by Country (2021–2032)

Figure 26. United States Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Canada Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Europe Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Europe Lipid Nanoparticle (LNP) CDMO Service Market Share by Country (2021–2032)

Figure 30. Germany Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. France Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. U.K. Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Italy Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Russia Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Ireland Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Asia-Pacific Lipid Nanoparticle (LNP) CDMO Service Market Share by Region (2021–2032)

Figure 38. China Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Japan Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. South Korea Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Southeast Asia Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. India Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Australia & New Zealand Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Latin America Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Latin America Lipid Nanoparticle (LNP) CDMO Service Market Share by Country (2021–2032)

Figure 46. Mexico Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Brazil Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Middle East & Africa Lipid Nanoparticle (LNP) CDMO Service Market Share by Country (2021–2032)

Figure 50. Israel Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Saudi Arabia Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. UAE Lipid Nanoparticle (LNP) CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Evonik Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 54. Helix Biotech Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 55. FUJIFILM Holdings Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 56. Merck Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 57. Ascendia Pharmaceuticals Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 58. Catalent Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 59. Polymun Scientific Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 60. Genevant Sciences Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 61. Cytiva Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 62. Croda International Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 63. Nippon Fine Chemical Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 64. Patheon Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 65. Biomay Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 66. Pace Analytical Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 67. CordenPharma Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 68. Vernal Biosciences Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 69. Lonza Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 70. Acuitas Therapeutics Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 71. Creative Biolabs Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 72. WuXi STA Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 73. GenScript Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 74. MicroNano Biologics Revenue Growth Rate in Lipid Nanoparticle (LNP) CDMO Service Business (2021–2026)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Lipid Nanoparticle (LNP) CDMO Service Market Research Report 2026

Published Date: 2026-01-08

Report Code: QYRE-Auto-16H20264

Global Lipid Nanoparticle (LNP) CDMO Service Market Research Report 2026

FEATURED COMPANIES

Lipid Nanoparticle (LNP) CDMO Service Market Size

Lipid Nanoparticle (LNP) CDMO Service Market

Scope of Lipid Nanoparticle (LNP) CDMO Service Market Report

Chapter Outline

FAQ for this report

How fast is Lipid Nanoparticle (LNP) CDMO Service Market growing?

What is the Lipid Nanoparticle (LNP) CDMO Service Market size in 2032?

Who are the main players in the Lipid Nanoparticle (LNP) CDMO Service Market report?

What are the Application segmentation covered in the Lipid Nanoparticle (LNP) CDMO Service Market report?

What are the Type segmentation covered in the Lipid Nanoparticle (LNP) CDMO Service Market report?

FEATURED COMPANIES